PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2143355
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2143355
Tissue Clearing market size was valued at US$ 138.7 Million in 2025, expanding at a CAGR of 10.3% from 2026 to 2033.
The tissue clearance methods help make tissues transparent and analyze the cells at an improved level. The tissue clarification methods provide researchers with 3D imaging that allows visualizing and studying the structure of the cells and the connection between them. The tissue clearance methods are currently being used in neurology, oncology, and regenerative medicine, such as the study of the neural circuitry in the brain, understanding of the behavior of cancer cells in cancerous tissues, and the regeneration of tissues, respectively. Furthermore, the increasing availability of the tissue clearance methods, along with the development of microscopes, software, and data analysis methods, will allow using them more extensively in the research and clinics in the future. As a result, the tissue-clearance techniques market is expected to increase in the forecast period.
Tissue Clearing Market- Market Dynamics
Rising Prevalence Of Neurodegenerative Diseases To Fuel Market Expansion
The rising prevalence of neurodegenerative diseases is expected to drive the Tissue Clearing market forward. Tissue clearing is a process in which brain and nerve tissues are rendered transparent in order to observe cells and neurones. For example, in June 2026, according to Neurology Org, there was an increase in the prevalence of Parkinson's disease by 1.4% annually; the prevalence of multiple sclerosis increased by 2.9% annually; and the prevalence of motor neurone disease increased by 2.8% annually. The study was carried out using national health data in Sweden and France that took into consideration the health situation of several hundred thousand people from Sweden and France. The reasons leading to an increase in the occurrence of the above neurodegenerative diseases were diverse and different; among the reasons were life expectancy and ageing of the population. These trends highlight the growing need for advanced tissue-clearing techniques in neurodegenerative disease research.
The Global Tissue Clearing market is segmented on the basis of Product, Tissue Type, Method Type, Application, End Use, and Region.
In the tissue clearing market, the aqueous-based clearing method represents a key method segment, as it utilizes aqueous-based solutions to dissolve the contents of the tissues while maintaining the tissue structure and fluorescence. This method finds applications in biological and biomedical research fields where the need arises to maintain the structural and molecular integrity of the tissues. In October 2025, Thermo Fisher Scientific, Inc. continued to offer the CytoVista(TM) Tissue Clearing/Staining Kit that provides an aqueous-compatible solution for clearing tissues and 3D cultures that will aid in obtaining tissues and 3D cultures ready for visualization. The method facilitates clearing and staining of the tissues while maintaining its compatibility with fluorescence-based visualization techniques. These developments are anticipated to drive the adoption of aqueous-based clearing methods in the field of biological and biomedical research.
Tissue Clearing Market- Geographical Insights
North America holds a significant share of the global Tissue Clearing market and was projected to have steady growth in the forecast period. There are several factors that would drive the market growth, including flourishing biotechnology and biopharmaceutical industries, a growing number of R&D activities, increased investments in neuroscience & cancer research. For example, in February 2026, according to the Cancer Research Institute (Org.), out of nearly 2.1 million cancer-diagnosed cases, around 626,000 deaths occurred, which means 5,800 newly diagnosed cases and 1,720 deaths on a daily basis in the U.S. In general, there has been a reduction in the cancer death rate in the U.S. by 34%.
About 4.8 million cancer deaths have been prevented during this period due to unmet needs for some cancers with high mortality rates. For example, a 13% survival rate for pancreatic cancer and an increase in the survival rate for metastatic melanoma from 16% to 35% within the last 25 years. Therefore, in order to overcome the unmet needs and to protect and increase the research funding, it is critical to the development of innovative cancer treatments.
The global tissue clearing market is witnessing growth and is also dynamic and rapidly changing because of advancements in technologies for sample preparation and image acquisition. There are automated and artificial intelligence-based solutions for tissue clearing technologies that have been developed. Some of the major companies operating in the tissue clearing market globally are Visikol, Inc., LifeCanvas Technologies, Bio-Techne, Thermo Fisher Scientific, Inc., and Corning Incorporated. The major players have established their presence in the tissue clearing space through innovative product launches, research and development investments, and collaborations. In October 2025, LifeCanvas Technologies introduced an open-top light sheet microscope called DALISPIM that utilizes Depth Adaptive Light Interface Technology for in vivo 3D imaging of large tissues. Therefore, the competitive outlook of the tissue clearing market is likely to witness extensive research and development, collaborations, and innovations.
In January 2026, Thermo Fisher highlighted the fact that it has showcased some of its new innovations that have been released in the year 2025. The innovations include the Thermo Scientific(TM) Krios(TM) 5 Cryo-TEM and the Thermo Scientific(TM) Vulcan(TM) Automated Lab for advanced biological research and automation.
In April 2025, Sartorius signed an agreement for acquiring MatTek Corp., inclusive of Visikol Inc., from BICO Group at an amount of $80 million, expanding the Sartorius product range in 3D microtissue models, cell cultures, and advanced tissue analysis systems. The acquisition was completed in July 2025.